Elation Health, Inc.

Elation Health, Inc. is a healthcare technology company focused on enhancing primary care through an innovative electronic health record (EHR) platform. Their solutions streamline clinical workflows and improve patient-provider interactions. Founded in 2010 in San Francisco, US, Elation Health provides a comprehensive EHR platform for primary care practices.

The founders, Conan Fong and Kyna Fong, have backgrounds in technology and healthcare. The company has raised a total of USD 50. 00 mn in funding, with its latest round being a Series D from investors including Ascend Partners and Generation Investment Management. The latest round completed also represents the total raised by the company to date, valuing it at USD 355.

31 mn. Elation Health specializes in an award-winning electronic health record (EHR) platform designed to enhance primary care practices through innovative technology solutions. Its primary offerings include the Elation EHR, Elation Billing, and Note Assist, which collectively streamline clinical workflows, billing processes, and documentation through AI-powered tools. The EHR focuses on improving patient-provider interactions by providing intuitive charting and seamless integrations with other healthcare applications, allowing for efficient management of clinical records and patient payments.

The Elation Billing solution further simplifies the billing workflow from patient check-in to payment receipt, while Note Assist serves as an intelligent medical scribe that reduces the burden of after-hours documentation, thereby optimizing the time that providers can spend with patients. Targeted primarily at independent practices and small to mid-sized healthcare providers, Elation Health's products are utilized across various geographical markets, including the United States and Canada, as well as parts of Europe and Asia. Elation Health generates revenue primarily through subscription-based pricing models for its EHR and billing solutions, along with service agreements that facilitate the integration of its technology within medical practices. The company's revenue stream is bolstered by ongoing partnerships with primary care physicians and healthcare groups, who rely on Elation's tools to enhance operational efficiency and patient engagement.

Transactions typically involve practices subscribing to the Elation EHR and Billing solutions, allowing them to manage their clinical workflows and billing processes directly through the platform. Pricing plans are structured to accommodate varying practice sizes and needs, aligning costs with the specific features and services utilized. Elation's flagship products, including Elation EHR and Elation Billing, are integral to the company's revenue model by providing essential tools that support value-based care and improve financial performance for healthcare providers. Elation Health is focused on expanding its product offerings and geographic reach.

The company is developing new features for its EHR platform aimed at enhancing usability and integration capabilities, with plans for a rollout in early 2024. Additionally, Elation Health seeks to penetrate deeper into the European and Asian markets by the end of 2024, utilizing its recent funding of USD 50. 00 mn from the Series D round to support these initiatives. This funding will help drive product development and market expansion efforts, positioning Elation Health to meet the growing demands within the primary care landscape.

Recently, SV Angel exited its stake in Elation Health, indicating ongoing interest and evolution in investor engagement.